ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Bellevue Life Sciences Acquisition Corporation

Bellevue Life Sciences Acquisition Corporation (BLACU)

3,36
0,00
(0,00%)
Geschlossen 22 März 9:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
3,36
Gebot
2,95
Fragen
3,25
Volumen
-
0,00 Tagesbereich 0,00
3,36 52-Wochen-Bereich 13,71
Marktkapitalisierung
Handelsende
3,36
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
3.044
Ausgegebene Aktien
6.430.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
26,27
Gewinn pro Aktie (EPS)
0,06
Erlöse
-
Nettogewinn
404k

Über Bellevue Life Sciences Acquisition Corporation

OSR is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating busin... OSR is a global healthcare company dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. Its current operating businesses (through three wholly-owned subsidiaries) include (i) developing oral immunotherapies for the treatment of cancer, (ii) developing design-augmented biologics for age-related and other degenerative diseases and (iii) neurovascular intervention medical device and systems distribution in Korea. OSR's vision is to acquire and operate a portfolio of innovative health-care related companies globally. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Hauptsitz
Dover, Delaware, USA
Gegründet
-
Bellevue Life Sciences Acquisition Corporation is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker BLACU. The last closing price for Bellevue Life Sciences A... was US$3,36. Over the last year, Bellevue Life Sciences A... shares have traded in a share price range of US$ 3,36 to US$ 13,71.

Bellevue Life Sciences A... currently has 6.430.000 shares in issue. The market capitalisation of Bellevue Life Sciences A... is US$21,60 million. Bellevue Life Sciences A... has a price to earnings ratio (PE ratio) of 26.27.

BLACU Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1003.363.363.3600CS
4003.363.363.3600CS
12-8.53-71.740958788911.8913.713.3630449.35219577CS
26-7.59-69.315068493210.9513.713.3613839.38322094CS
52-7.925-70.225963668611.28513.713.367749.57863145CS
156-6.81-66.961651917410.1713.713.36503610.16437665CS
260-6.81-66.961651917410.1713.713.36503610.16437665CS

BLACU - Frequently Asked Questions (FAQ)

What is the current Bellevue Life Sciences A... share price?
The current share price of Bellevue Life Sciences A... is US$ 3,36
How many Bellevue Life Sciences A... shares are in issue?
Bellevue Life Sciences A... has 6.430.000 shares in issue
What is the market cap of Bellevue Life Sciences A...?
The market capitalisation of Bellevue Life Sciences A... is USD 21,6M
What is the 1 year trading range for Bellevue Life Sciences A... share price?
Bellevue Life Sciences A... has traded in the range of US$ 3,36 to US$ 13,71 during the past year
What is the PE ratio of Bellevue Life Sciences A...?
The price to earnings ratio of Bellevue Life Sciences A... is 26,27
What is the reporting currency for Bellevue Life Sciences A...?
Bellevue Life Sciences A... reports financial results in USD
What is the latest annual profit for Bellevue Life Sciences A...?
The latest annual profit of Bellevue Life Sciences A... is USD 404k
What is the registered address of Bellevue Life Sciences A...?
The registered address for Bellevue Life Sciences A... is 8 THE GREEN, STE R, KENT, DOVER, DELAWARE, 19901
Which industry sector does Bellevue Life Sciences A... operate in?
Bellevue Life Sciences A... operates in the SURGICAL,MED INSTR,APPARATUS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
SGLYSingularity Future Technology Ltd
US$ 1,6799
(143,43%)
30,76M
WINVWinVest Acquisition Corporation
US$ 25,00
(107,30%)
463
VVPRVivoPower International PLC
US$ 1,2899
(52,13%)
65,08M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
GLTOGalecto Inc
US$ 6,00
(44,93%)
10,71M
YHCLQR House Inc
US$ 0,40
(-82,38%)
38,32M
KZIAKazia Therapeutics Ltd
US$ 0,9759
(-80,02%)
55,66k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
TCBPTC BioPharm Holdings PLC
US$ 0,5046
(-67,23%)
5,9M
SOWGSow Good Inc
US$ 1,53
(-44,36%)
698,02k
DMNDamon Inc
US$ 0,0373
(-70,02%)
304,17M
NVDANVIDIA Corporation
US$ 117,70
(-0,70%)
264,42M
RNAZTransCode Therapeutics Inc
US$ 1,12
(45,45%)
216,22M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,03
(10,66%)
175,77M
HOLOMicroCloud Hologram Inc
US$ 1,00
(32,36%)
141,98M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock